Be Part of Research has already been used to enrol more than 90,000 people across the UK to over 100 studies, including the UK’s first norovirus vaccine trial ... the diversity within it to produce ...

Moderna, Inc. (NASDAQ:MRNA – Get Free Report) has been given an average rating of “Hold” by the twenty-three analysts that ...

A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...